New Journey Health Technology Co., Ltd. logo

New Journey Health Technology Co., Ltd. (002219)

Market Open
7 Aug, 06:57
XSHE XSHE
¥
2. 14
+0.04
+1.9048%
¥
7.89B Market Cap
- P/E Ratio
0.11% Div Yield
90.85M Volume
- Eps
¥ 2.1
Previous Close
Add Transaction
Day Range
2.06 2.14
Year Range
1.69 2.97
Want to track 002219 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

002219 trading today higher at ¥2.14, an increase of 1.9048% from yesterday's close, completing a monthly increase of 23.6994% or ¥0.41. Over the past 12 months, 002219 stock gained 0%.
002219 is not paying dividends to its shareholders.
The last earnings report, released on May 09, 2025, exceeded the consensus estimates by 0.0076%. On average, the company has surpassed earnings expectations by 0.0053%, based on the last three reports.
New Journey Health Technology Co., Ltd. has completed 7 stock splits, with the recent split occurring on Jun 22, 2016.
The company's stock is traded on one exchange.

002219 Chart

People also search for

Guangzhou Wondfo Biotech Co., Ltd.
¥ 17.89
0%
China Reform Health Management Co., Ltd.
¥ 7.52
-0.2653%
Acro Biosystems Co., Ltd.
¥ 81.88
+5.3797%
EIT Environmental Development Group Co., Ltd.
¥ 16.54
-1.0174%
Huapont Life Sciences Co., Ltd.
¥ 4.5
+0.6711%

New Journey Health Technology Co., Ltd. (002219) FAQ

What is the stock price today?

The current price is ¥2.14.

On which exchange is it traded?

New Journey Health Technology Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 002219.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.11%.

What is its market cap?

As of today, the market cap is 7.89B.

Has New Journey Health Technology Co., Ltd. ever had a stock split?

New Journey Health Technology Co., Ltd. had 7 splits and the recent split was on Jun 22, 2016.

New Journey Health Technology Co., Ltd. Profile

Health Care Technology Industry
Healthcare Sector
Mr. Liu Jun CEO
XSHE Exchange
CNE1000009R5 ISIN
CN Country
9,097 Employees
28 Feb 2014 Last Dividend
22 Jun 2016 Last Split
6 Mar 2008 IPO Date

Overview

New Journey Health Technology Group Co., LTD, previously known as Hengkang Medical Group Co., Ltd., is a comprehensive healthcare company. Since its establishment in 2001, it has committed to the provision of medical services and pharmaceutical products within China and on an international scale. The company administers a network of regional medical centers along with tertiary and second-level hospitals, delivering advanced medical care. Its operations extend beyond clinical services into multiple sectors including research and development, production, sale of pharmaceutical products, Chinese herbal medicine planting, technology consulting, investment management, and even retail and catering services, making it a versatile entity in the healthcare and pharmaceutical industry. Headquartered in Beijing, China, New Journey Health Technology Group Co., LTD embodies a multifaceted approach to healthcare, combining traditional Chinese medicine with modern medical practices.

Products and Services

  • Duyiwei capsules and tablets:
  • These are pharmaceutical products designed for specific therapeutic uses, though the text does not specify their exact application. The production and sale of these capsules and tablets represent a key aspect of the company's pharmaceutical branch.

  • Shenqi Wuweizi tablets:
  • Part of the company's commitment to integrating traditional Chinese medicine into contemporary healthcare solutions, Shenqi Wuweizi tablets are likely formulated from natural herbs, aimed at improving overall health and well-being.

  • Maiping tablets:
  • Another product that underscores New Journey Health Technology Group's dedication to offering pharmaceutical solutions derived from herbal medicine. Maiping tablets, like other products, are developed following rigorous research and development protocols to ensure efficacy and safety.

  • Qianlie Antong tablets:
  • These tablets are targeted at addressing specific health concerns, potentially in the realm of men's health or urinary conditions, judging by the name. The company's pharmaceutical segment ensures the availability of such specialized treatments.

  • Gongliuning capsules:
  • Gongliuning capsules are presumably designed for women's health, given the patterns in traditional Chinese medicine product naming. They exemplify New Journey Health Technology Group's focused approach on gender-specific health issues.

In addition to these pharmaceutical products, New Journey Health Technology Group Co., LTD provides extensive services in Chinese herbal medicine planting, reflecting its root in traditional practices. It also involves in technology research, development, and consulting, ensuring that its practices are backed by the latest scientific findings, along with handling investment management and consulting. Asset, medical project, and industrial investment facets of the company demonstrate its capability in advancing healthcare infrastructure. The diversity extends to drug discovery, which is crucial for expanding its portfolio of health solutions. Moreover, the company ventures into retail, offering its medical and health products directly to consumers, and catering businesses, which may serve to support its healthcare facilities or offer health-oriented food services.

Contact Information

Address: Fortune Financial Center, Beijing, China, 100020
Phone: 86 10 8523 5987